Strata Acquires Ohio Valley Perfusion Associates
Rhea-AI Summary
Strata (Nasdaq: SRTA) completed the acquisition of Ohio Valley Perfusion Associates (OVPA), a regional perfusion services provider in Ohio and Pennsylvania, for an approximate purchase price of $1 million.
OVPA brings a team of eight certified clinicians and services including ECMO, autotransfusion and organ recovery, and the deal was described as a mid-single-digit EBITDA multiple consistent with Strata's M&A strategy.
Positive
- Geographic expansion into Eastern Ohio and Western Pennsylvania
- Adds ECMO and organ recovery services to Strata's clinical platform
- Recurring-contract profile with multi-year contracts and high customer retention
Negative
- Small scale: OVPA operates with eight clinicians
- Purchase price of approximately $1 million indicates limited near-term revenue contribution
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of perfusion services to cardiac surgery programs in Ohio and Pennsylvania.
“Expanding our presence in Eastern Ohio and Western Pennsylvania is an important step in strengthening Strata’s regional clinical platform,” said Louis Verdetto, CEO of Strata’s Clinical Services Division. “These programs align well with our existing operations and allow us to further leverage our team of highly trained perfusionists to support cardiac surgery programs while continuing to expand advanced services such as ECMO support and organ recovery.”
“This transaction represents an exciting opportunity for our team and the programs we support,” said Richard Marcotte, Founder of Ohio Valley Perfusion Associates. “Through our partnership with Strata, we will gain access to additional clinical resources, technology, and infrastructure that will enable us to expand our services and better support our hospital partners across the region.”
“This bolt on acquisition is a perfect fit with our existing clinical operations and M&A strategy while coming at an attractive mid-single digit multiple of EBITDA, consistent with our target valuation framework,” said Mat Schneider, CFO of Strata’s Clinical Services Division. “The cardiac perfusion business has several highly attractive attributes including recurring revenue, multi-year contracts, high customer retention and the industry remains fragmented. In addition to our focus on growing our transplant related businesses, we view cardiac perfusion as an attractive platform to grow both organically and through acquisitions over the coming years.”
Ohio Valley Perfusion Associates serves customers in Ohio and Pennsylvania providing perfusion and related services including ECMO and autotransfusion with a team of eight highly trained and certified clinicians. The purchase price is approximately
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit https://stratacritical.com/.
Contacts
Mathew Schneider
investors@srta.com
